TOKYO, Jan. 19, 2026 /PRNewswire/ — Sakai Clinic 62 (Location: Shibuya-ku, Tokyo; Founder & Medical Director: Mari Sakai) announces that Dr. Mari Sakai held a dialogueTOKYO, Jan. 19, 2026 /PRNewswire/ — Sakai Clinic 62 (Location: Shibuya-ku, Tokyo; Founder & Medical Director: Mari Sakai) announces that Dr. Mari Sakai held a dialogue

Sakai Clinic 62 Founder & Medical Director Mari Sakai Holds Dialogue with Peter Nobel, Chairman of the Nobel Sustainability Trust, Declaring Global Leadership as a Pioneer of Medical Sustainability

TOKYO, Jan. 19, 2026 /PRNewswire/ — Sakai Clinic 62 (Location: Shibuya-ku, Tokyo; Founder & Medical Director: Mari Sakai) announces that Dr. Mari Sakai held a dialogue with Mr. Peter Nobel, Chairman of the Nobel Sustainability Trust (NST), to discuss the international promotion of sustainability within the medical field.

The Nobel Sustainability Trust (NST) is an international foundation established by members of the Nobel family, dedicated to advancing sustainability by bridging scientific research and real-world implementation. During this dialogue, insights from regenerative medicine—including telomere injections and infusions developed by Dr. Sakai—were exchanged alongside NST’s global sustainability philosophy. The discussion revealed strong alignment between both parties and highlighted significant potential for future collaboration.

Dr. Sakai has long advocated that realizing the sustainability of both the human mind and body through regenerative medicine is a critical mission of modern healthcare. Through this dialogue, she further reinforced the importance of communicating the concept of medical sustainability to the international community.

Following the discussion, Dr. Sakai commented:

“This dialogue reaffirmed my strong sense of mission to present the value of medical sustainability to the world and to advance initiatives that safeguard the health and well-being of future generations. As Sakai Clinic 62, we are committed to acting as a pioneer in medical sustainability and will continue to promote these efforts in collaboration with domestic and international networks.”

Sakai Clinic 62 will continue to integrate a global perspective into its initiatives, striving to advance medical sustainability and contribute to the extension of healthy life expectancy and the sustainability of society through regenerative medicine.

Contact Information
8F TOP HILLS GARDEN Dogenzaka,
2-11-6 Dogenzaka, Shibuya-ku, Tokyo 150-0043, Japan
Tel: +81-3-6455-1813
Email: [email protected] 
Website: https://www.sakai-clinic62.jp/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sakai-clinic-62-founder–medical-director-mari-sakai-holds-dialogue-with-peter-nobel-chairman-of-the-nobel-sustainability-trust-declaring-global-leadership-as-a-pioneer-of-medical-sustainability-302662075.html

SOURCE Sakai Clinic62

Market Opportunity
Intuition Logo
Intuition Price(TRUST)
$0.09546
$0.09546$0.09546
-1.05%
USD
Intuition (TRUST) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
XRP Yield Strategies vs. Traditional Staking: Which Offers the Highest Returns for Long-Term Holders?

XRP Yield Strategies vs. Traditional Staking: Which Offers the Highest Returns for Long-Term Holders?

[January 20, 2026] — As the cryptocurrency market matures, investors are no longer content with simply holding (HODL) but are beginning to seek the “productivity
Share
Coincentral2026/01/20 23:25
Value Gene Report: Humanoid Robots to Reshape Food Manufacturing Within Six Years as Labor Crisis Deepens

Value Gene Report: Humanoid Robots to Reshape Food Manufacturing Within Six Years as Labor Crisis Deepens

DALLAS, Jan. 20, 2026 /PRNewswire/ — Value Gene Consulting Group today released a new report, “How Humanoids Will Reshape Food Manufacturing,” stating that humanoids
Share
AI Journal2026/01/20 23:15